Netanyahu Signals Plan to End Reliance on U.S. Military Aid Within 10 Years 
Trump-Xi Beijing Summit to Focus on Trade, Taiwan, and Boeing Deal 
Germany Rejects Putin’s Proposal for Schroeder to Mediate Ukraine Peace Talks 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
Trump Announces Russia-Ukraine Ceasefire for May 9-11 Amid Ongoing Peace Talks 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Qatar Condemns Drone Strike as Iran Conflict Threatens Gulf Shipping and Global Markets 
Ukraine-Russia Ceasefire Confirmed as Prisoner Swap Deal Advances 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Senate Stablecoin Bill Sparks Clash Between Banks and Crypto Industry 
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case 
Qatar LNG Tanker Crosses Strait of Hormuz Amid Iran War Tensions 
President Donald Trump had previously touted a two-drug combination as a potential treatment for the COVID-19. However, the US National Institutes of Health (NIH) warned that using the combination might expose coronavirus patients to some serious side effects.
President Donald Trump previously touted a drug combination as a possible treatment for the coronavirus in press briefings and social media posts. “Hydroxychloroquine and azithromycin, taken together, have a real chance to be one of the biggest game-changers in the history of medicine,” Trump tweeted in March, according to Financial Times. “The FDA has moved mountains - Thank You! Hopefully, they will BOTH (H works better with A, International Journal of Antimicrobial Agents)”
“What do you have to lose?” Trump said a couple of weeks ago. However, the President has been criticized by scientists “for promoting the drugs without conclusive scientific evidence that they work,” Forbes reported. After his comments, there were reported shortages of hydroxychloroquine for patients using the drug as a treatment for rheumatoid arthritis or lupus.
However, a panel from the NIH recommended against the use of hydroxychloroquine and azithromycin because they are “associated with QTc prolongation in patients with COVID-19.” According to Forbes, “QTc prolongation is associated with abnormalities in heart rhythm or sudden cardiac death.”
The experts also warned that the drug combination might result in possible toxicities, according to FT, The toxicities could result in further serious side effects, which include poisoning.
The NIH report was done by a panel of health experts that included members of the team led by Anthony Fauci. The report was published on NIH’s website on Tuesday.
The study involved 368 COVID-19 patients at hospitals run by the Veterans Health Administration. Researchers found out that there were more deaths among patients taking a combination of hydroxychloroquine and azithromycin compared to patients who were not taking the drug combo.
At a recent news conference, Trump promised to look into the NIH report but he also clarified that he is not aware of the study. “There have been some very good reports and perhaps this one’s not a good report, but we’ll be looking at it,” the President said.
